Range
7.35 - 7.58
Vol / Avg.
47.3K/103.7K
Div / Yield
-
52 Wk
7.1 - 30.35
Mkt Cap
1B
Payout Ratio
-
Open
7.44
P/E
-
EPS
-0.82
Shares
136.6M
Outstanding
Sector: Health Care.Industry: Biotechnology
MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases. MorphoSys is advancing its own pipeline of new drug candidates and has created antibodies that are developed by partners in different areas of unmet medical need. Tremfya (guselkumab) - developed by Janssen Research & Development, LLC and marketed by Janssen Biotech, Inc. for the treatment of plaque psoriasis - became the first drug based on MorphoSys antibody technology to receive regulatory approval. The U.S. Food and Drug Administration granted accelerated approval of the company's proprietary product Monjuvi (tafasitamab-cxix) in combination with lenalidomide for patients with a certain type of lymphoma.

Earnings

see more
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2022-03-14
REV
Q3 2021Est.ActualSurprise
EPS-0.740-0.970 -0.2300
REV49.530M48.636M-894.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

MorphoSys Questions & Anwsers

Q

How do I buy MorphoSys (MOR) stock?

A

You can purchase shares of MorphoSys (NASDAQ: MOR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are MorphoSys's (MOR) competitors?

Q

What is the target price for MorphoSys (MOR) stock?

A

The latest price target for MorphoSys (NASDAQ: MOR) was reported by Morgan Stanley on January 14, 2022. The analyst firm set a price target for 0.00 expecting MOR to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for MorphoSys (MOR)?

A

The stock price for MorphoSys (NASDAQ: MOR) is $7.57 last updated Fri Jan 28 2022 21:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does MorphoSys (MOR) pay a dividend?

A

There are no upcoming dividends for MorphoSys.

Q

When is MorphoSys (NASDAQ:MOR) reporting earnings?

A

MorphoSys’s $Q4 earnings are confirmed for after-market on March 14, 2022.

Q

Is MorphoSys (MOR) going to split?

A

There is no upcoming split for MorphoSys.

Q

What sector and industry does MorphoSys (MOR) operate in?

A

MorphoSys is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.